{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:22:20Z","timestamp":1767651740602},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1053\/ctrv.2002.0245","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"351-363","source":"Crossref","is-referenced-by-count":42,"title":["Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine"],"prefix":"10.1053","volume":"27","author":[{"given":"E.J","family":"Estlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ctrv.2002.0245_RF1","first-page":"97","article-title":"Optimal current treatment of childhood acute lymphoblastic leukaemia","volume":"65","author":"Simone","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1053\/ctrv.2002.0245_RF2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(95)90164-7","article-title":"Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X","volume":"345","author":"Chessells","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2002.0245_RF3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V92.2.411","article-title":"Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukaemia","volume":"92","author":"Pui","year":"1998","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1200\/JCO.1991.9.6.1012","article-title":"Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukaemia: a report of the CCG-161 study by the Children's Cancer Study Group","volume":"9","author":"Bleyer","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2002.0245_RF5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.1996.14.3.911","article-title":"High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukaemia: Results of protocol ALL VI form the Dutch Childhood Leukaemia Study Group","volume":"14","author":"Veerman","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2002.0245_RF6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1200\/JCO.1998.16.1.246","volume":"16","author":"Mahoney","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2002.0245_RF7","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1200\/JCO.1994.12.9.1939","article-title":"Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukaemia; a Pediatric Oncology Group study","volume":"12","author":"Land","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2002.0245_RF8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","article-title":"Augmented post-induction therapy for children with high-risk acute lymphoblastic leukaemia and a slow response to initial therapy","volume":"338","author":"Nachman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/ctrv.2002.0245_RF9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.1991.tb04415.x","article-title":"Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)","volume":"78","author":"Eden","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1053\/ctrv.2002.0245_RF10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1126\/science.2649979","article-title":"The purine path to chemotherapy","volume":"244","author":"Elion","year":"1989","journal-title":"Science"},{"key":"10.1053\/ctrv.2002.0245_RF11","first-page":"2475","article-title":"Enzymic capacities of purine de novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues","volume":"44","author":"Natsumeda","year":"1984","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0166-6851(87)90185-X","article-title":"Purification of hypoxanthine-guanine phosphoribosyltransferase of Plasmodium lophurae","volume":"23","author":"Schimandle","year":"1987","journal-title":"Mol Biochem Parasitol"},{"key":"10.1053\/ctrv.2002.0245_RF13","first-page":"1141","article-title":"Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase","volume":"47","author":"Krynetski","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF14","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/0006-2952(69)90069-0","article-title":"Inhibition of phosphoribosyl pyrophosphate amidotransferase form Erlich ascites-tumour cells by thiopurine nucleotides","volume":"18","author":"Tay","year":"1968","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1357-2725(98)00053-3","article-title":"Metabolic effects of thiopurine derivatives against human CCRF-CEM leukaemia cells","volume":"30","author":"Shi","year":"1998","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1053\/ctrv.2002.0245_RF16","first-page":"235","article-title":"Purine antimetabolites","author":"Hande","year":"1996"},{"key":"10.1053\/ctrv.2002.0245_RF17","first-page":"4156","article-title":"Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines","volume":"45","author":"Zimm","year":"1985","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0145-2126(92)90033-4","article-title":"Relation of 5\u2032-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukaemia","volume":"16","author":"Pieters","year":"1992","journal-title":"Leukaemia Res"},{"key":"10.1053\/ctrv.2002.0245_RF19","first-page":"802","article-title":"Consequences of 6-thioguanine incorporation into DNA on polymerase, ligase and endonuclease function","volume":"42","author":"Ling","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF20","first-page":"1","article-title":"The role of DNA mismatch repair in drug resistance","volume":"4","author":"Fink","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-2952(94)00387-2","article-title":"Reversal of methylmercaptopurine cytotoxicity by purine ribonucleotides and adenine","volume":"49","author":"Stet","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF22","first-page":"5387","article-title":"6-thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukaemia cells","volume":"54","author":"Morgan","year":"1994","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF23","first-page":"738","article-title":"A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine","volume":"34","author":"Tidd","year":"1974","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0145-2126(94)90159-7","article-title":"The cytotoxicity of thioguanine versus mercaptopurine in acute lymphoblastic leukaemia","volume":"18","author":"Adamson","year":"1994","journal-title":"Leukaemia Res"},{"key":"10.1053\/ctrv.2002.0245_RF25","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0006-2952(96)00041-X","article-title":"Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukaemic T-lymphocytes","volume":"51","author":"da Silva","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF26","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/0006-2952(93)90333-R","article-title":"Desulfuration of 6-mercaptopurine: The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukaemic cells","volume":"46","author":"Adamson","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF27","first-page":"3861","volume":"86","author":"Klumper","journal-title":"In vitro"},{"key":"10.1053\/ctrv.2002.0245_RF28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0145-2126(94)90159-7","article-title":"The cytotoxicity of thioguanine versus mercaptopurine in acute lymphoblastic leukaemia","volume":"18","author":"Adamson","year":"1994","journal-title":"Leukaemia Res"},{"key":"10.1053\/ctrv.2002.0245_RF29","first-page":"1670","article-title":"Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based continuing therapy","volume":"55","author":"Warren","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008571-199608000-00001","article-title":"Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms","volume":"6","author":"Krynetski","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1053\/ctrv.2002.0245_RF31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0009-9236(97)90152-1","article-title":"Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms","volume":"62","author":"Otterness","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/ctrv.2002.0245_RF32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2125.1997.t01-1-00607.x","article-title":"Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity","volume":"44","author":"Lennard","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002800050816","article-title":"Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukaemia receiving 6-thioguanine versus 6-mercaptopurine","volume":"42","author":"Erb","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/clpt.1986.178","article-title":"Oral 6-mercaptopurine in childhood leukaemia: Parent drug pharmacokinetics and active metabolite concentrations","volume":"40","author":"Lennard","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/ctrv.2002.0245_RF35","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1200\/JCO.1989.7.12.1816","article-title":"Varaible mercaptopurine metabolism and risk of relapse in childhood acute lymphoblastic leukaemia","volume":"7","author":"Lennard","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2002.0245_RF36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2125.1997.t01-1-00607.x","article-title":"Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity","volume":"44","author":"Lennard","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF37","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","article-title":"Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukaemic blasts from children with acute lymphoblastic leukaemia","volume":"85","author":"McLeod","year":"1995","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF38","first-page":"109","article-title":"Antifolates","author":"Allegra","year":"1996"},{"key":"10.1053\/ctrv.2002.0245_RF39","first-page":"2346","article-title":"Mechanism of cell death following thymidylate synthase inhibition: 2\u2032-deoxyuridine-5\u2032-triphosphate accumulation, DNA damage and growth inhibition following exposure to CB3717 and dipyridamole","volume":"51","author":"Curtin","year":"1991","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF40","first-page":"325","article-title":"Thymidine rescue of high-dose methotrexate in humans","volume":"38","author":"Howell","year":"1978","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1097-0215(19960328)66:1<29::AID-IJC6>3.0.CO;2-0","article-title":"The influence of drug-exposure conditions on the development of resistance to methotrexate or ZD1694 in culture human leukaemia cells","volume":"66","author":"Takemura","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1053\/ctrv.2002.0245_RF42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.52.1.155","article-title":"Differences in folylpolyglutamyl synthase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukaemic lymphoblasts: Mechanisms for lineage differences in methotrexate polyglutamation and cytotoxicity","volume":"52","author":"Galpin","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF43","first-page":"1641","article-title":"Methotrexate cytotoxicity for L5178Y\/Asn\u2212 lymphoblasts: Relationship of dose and duration of exposure to tumour cell viability","volume":"42","author":"Keefe","year":"1982","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF44","first-page":"1815","article-title":"Evolution of methotrexate resistance of human leukaemia cells in vitro","volume":"45","author":"Ohnuma","year":"1985","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF45","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1016\/S0021-9258(18)38101-8","article-title":"Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines","volume":"266","author":"McCloskey","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1053\/ctrv.2002.0245_RF46","first-page":"1996","article-title":"Cross resistance studies of folylpolyglutamate synthetase deficient, methotrexate resistant CCRF-CEM human leukaemia sublines","volume":"7","author":"McGuire","year":"1993","journal-title":"Leukaemia"},{"key":"10.1053\/ctrv.2002.0245_RF47","first-page":"2548","article-title":"The impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition ofde novo thymidylate and purine biosynthesis in CCRF-CEM cell lines","volume":"5","author":"Barnes","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF48","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V89.3.1013","article-title":"Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphoblastic leukaemia and is associated with decreased reduced folate carrier expression","volume":"89","author":"Gorlick","year":"1997","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF49","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood.V85.2.500.500","article-title":"Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukaemia","volume":"85","author":"Matherly","year":"1995","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF50","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood.V90.2.578","article-title":"Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukaemia in children","volume":"90","author":"Matherly","year":"1997","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood.V76.1.44.44","article-title":"Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukaemia: A pilot prognostic factor analysis","volume":"76","author":"Whitehead","year":"1990","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF52","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V80.5.1316.1316","article-title":"Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (>50 chromosomes) B-lineage acute lymphoblastic leukaemia: a Pediatric Oncology Group Study","volume":"80","author":"Whitehead","year":"1992","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF53","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood.V93.5.1643","article-title":"Reduced folate carrier expression in acute lymphoblastic leukaemia, a mechanism for pliody but not lineage differences in methotrexate accumulation","volume":"93","author":"Belkov","year":"1999","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF54","first-page":"1000","article-title":"Decreased polyglutamation of methotrexate in acute lymphoblastic leukaemia blasts in adults compared to children with this disease","volume":"7","author":"Goker","year":"1993","journal-title":"Leukaemia"},{"key":"10.1053\/ctrv.2002.0245_RF55","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0006-2952(97)00681-3","article-title":"Increased concentrations of methylated 6-mercaptopurine metabolites and 6-thioguanine nucleotides in human leukaemic cells in vitro by methotrexate","volume":"55","author":"Giverhaug","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF56","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/clpt.1991.205","article-title":"Human liver xanthine oxidase: nature and extent of individual variation","volume":"50","author":"Guerciolini","year":"1991","journal-title":"Clin Pharm Ther"},{"key":"10.1053\/ctrv.2002.0245_RF57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00008571-199208000-00002","article-title":"Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isoenzymes","volume":"2","author":"Szumlanski","year":"1992","journal-title":"Pharmacogenetics"},{"key":"10.1053\/ctrv.2002.0245_RF58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF00279977","article-title":"Intra-individual variation in 6-mercaptopurine pharmacokinetics during oral continuing therapy of children with acute lymphoblastic leukaemia","volume":"40","author":"Lafolie","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3476(05)80751-6","article-title":"Dose-dependent kinetics of orally administered6-mercaptopurine in children with leukaemia","volume":"119","author":"Kato","year":"1991","journal-title":"J Pediatrics"},{"key":"10.1053\/ctrv.2002.0245_RF60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002280050339","article-title":"Pharmacokinetics and distribution of 6-mercaptopurine administered intravenously in children with lymphoblastic leukaemia","volume":"53","author":"Jacqz-Aigrain","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF61","first-page":"6079","article-title":"Intrathecal 6-mercaptopurine: preclinical pharmacology, Phase I\/II trial, and pharmacokinetic study","volume":"51","author":"Adamson","year":"1991","journal-title":"Cancer Res"},{"key":"10.1053\/ctrv.2002.0245_RF62","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/clpt.1987.45","article-title":"The effect of methotrexate on the bioavailability of oral 6-mercaptopurine","volume":"41","author":"Balis","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/ctrv.2002.0245_RF63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199802193380803","article-title":"Conventional compared with individualised chemotherapy for childhood acute lymphoblastic leukaemia","volume":"338","author":"Evans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/ctrv.2002.0245_RF64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00570494","article-title":"Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia","volume":"20","author":"Pearson","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF65","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V92.10.3569","article-title":"Pharmacokinetics and pharmacodynamics of methotrextare and mercaptopurine in children with lower risk acute lymphoblastic leukaemia: A joint Children's Cancer Group and Pediatric Oncology Branch study","volume":"10","author":"Balis","year":"1998","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","article-title":"Methotrexate distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections","volume":"293","author":"Shapiro","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1053\/ctrv.2002.0245_RF67","first-page":"703","article-title":"Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in non-toxic patients after lumbar injection","volume":"61","author":"Bleyer","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"10.1053\/ctrv.2002.0245_RF68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood.V18.4.431.431","article-title":"Studies of sequential and combination antimetabolite therapy in acute leukaemia: 6-mercaptopurine and methotrexate","volume":"18","author":"Frei","year":"1961","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF69","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.V21.6.699.699","article-title":"The effect of 6-mercaptopurine on the duration of steroid-induced remissions in acute leukaemia: A model for evaluation of other potentially useful therapy","volume":"21","author":"Freireich","year":"1963","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF70","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1182\/blood.V26.5.642.642","article-title":"The effectivess of combinations of antileukaemic agents in inducing and maintaining remission induction in children with acute leukaemia","volume":"26","author":"Frei","year":"1965","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/adc.62.1.12","article-title":"Intensive consolidation chemotherapy for acute leukaemia (UKALL X pilot study)","volume":"62","author":"Pinkerton","year":"1987","journal-title":"Arch Dis Child"},{"key":"10.1053\/ctrv.2002.0245_RF72","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/adc.66.4.462","article-title":"Importance of 6-mercaptopurine dose in lymphoblastic leukaemia","volume":"66","author":"Hale","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1053\/ctrv.2002.0245_RF73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s002800050457","article-title":"6-mercaptopurine dose escalation and its effect on drug tolerance in childhood acute lymphoblastic leukaemia","volume":"38","author":"Welch","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/ctrv.2002.0245_RF74","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817","article-title":"Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukaemia","volume":"93","author":"Relling","year":"1999","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM199007053230104","article-title":"Systemic exposure to 6-mercaptopurine as a prognostic indicator in acute lymphoblastic leukaemia in children","volume":"323","author":"Koren","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/ctrv.2002.0245_RF76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ijc.2910510208","article-title":"Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukaemia: Relation with immunophenotype, in vitro drug resistance and clinical prognosis","volume":"51","author":"Pieters","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1053\/ctrv.2002.0245_RF77","doi-asserted-by":"crossref","unstructured":"Rambotti, P, Davis, S, Hypoxanthine-guanine phosphoribosyltransferase activity in normal and leukaemic lymphocytes, Br J Haematol, 49, 23, 28","DOI":"10.1111\/j.1365-2141.1981.tb07193.x"},{"key":"10.1053\/ctrv.2002.0245_RF78","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood.V92.8.2856","article-title":"The relationship between thiopurine methyltransferase activity and genotype in blasts form patients with acute leukaemia","volume":"92","author":"Coulthard","year":"1998","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF79","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0145-2126(92)90033-4","article-title":"Relation of 5\u2032-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukaemia","volume":"16","author":"Pieters","year":"1992","journal-title":"Leukaemia Res"},{"key":"10.1053\/ctrv.2002.0245_RF80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia","volume":"336","author":"Lennard","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2002.0245_RF81","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0140-6736(94)92400-7","article-title":"Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia","volume":"343","author":"Lilleyman","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/ctrv.2002.0245_RF82","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood.V18.4.431.431","article-title":"Studies of sequential and combination antimetabolite therapy in acute leukaemia: 6-mercaptopurine and methotrexate","volume":"18","author":"Frei","year":"1961","journal-title":"Blood"},{"key":"10.1053\/ctrv.2002.0245_RF83","first-page":"203","article-title":"Modification of treatment schedules in the management of advanced mouse leukaemia with amethopterin","volume":"17","author":"Goldin","year":"1956","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ctrv.2002.0245_RF84","first-page":"187","article-title":"New treatment schedule with improved survival in childhood leukemia","volume":"194","author":"Acute Leukemia Group","year":"1965","journal-title":"JAMA"},{"key":"10.1053\/ctrv.2002.0245_RF85","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cpt196673332","article-title":"The role of vincristine in the treatrment of childhood acute leukamia","volume":"7","author":"Karon","year":"1966","journal-title":"Clin Pharm Ther"},{"key":"10.1053\/ctrv.2002.0245_RF86","first-page":"527a","article-title":"Dexamaethasone decreases central nervous system (CNS) relapse and improves event free survival in lower risk acute lymphoblastic leukaemia","volume":"17","author":"Bostrom","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/ctrv.2002.0245_RF87","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2000.18.7.1508","article-title":"Six months of maintenanace chemotherapy after intensified treatment for acute lymphoblastic leukaemia of childhood","volume":"18","author":"Toyoda","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2002.0245_RF88","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.1989.7.3.316","article-title":"Three versus five years of continuing therapy are equivalent in childhood acute lymphoblastic leukaemia: a report from the Children's Cancer Study Group","volume":"7","author":"Miller","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1053\/ctrv.2002.0245_RF89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1097-0142(197102)27:2<247::AID-CNCR2820270202>3.0.CO;2-C","article-title":"Drug dosage and remission duration in childhood lymphocytic leukaemia","volume":"27","author":"Pinkel","year":"1971","journal-title":"Cancer"},{"key":"10.1053\/ctrv.2002.0245_RF90","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737202902458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737202902458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:05:45Z","timestamp":1682139945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737202902458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0305737202902458"],"URL":"https:\/\/doi.org\/10.1053\/ctrv.2002.0245","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}